| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review
|
Hirte, Hal
|
|
|
162 |
C |
p.
|
article
|
| 2 |
Critical review of oncology clinical trial design under non-proportional hazards
|
Ananthakrishnan, Revathi
|
|
|
162 |
C |
p.
|
article
|
| 3 |
Cross-talk between next generation sequencing methodologies to identify genomic signatures of esophageal cancer
|
Verma, Renu
|
|
|
162 |
C |
p.
|
article
|
| 4 |
Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications
|
De Nola, Rosalba
|
|
|
162 |
C |
p.
|
article
|
| 5 |
Editorial Board
|
|
|
|
162 |
C |
p.
|
article
|
| 6 |
Effectiveness of photobiomodulation therapy in radiation dermatitis: A systematic review and meta-analysis
|
Aguiar, Beatriz Regina Lima de
|
|
|
162 |
C |
p.
|
article
|
| 7 |
Impact of tumor site on the prognosis of salivary gland neoplasms: A systematic review and meta-analysis
|
dos Santos, Erison Santana
|
|
|
162 |
C |
p.
|
article
|
| 8 |
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm
|
Marotta, Vincenzo
|
|
|
162 |
C |
p.
|
article
|
| 9 |
Late radiation effects in survivors of head and neck cancer: State of the science
|
Ortigara, Gabriela Barbieri
|
|
|
162 |
C |
p.
|
article
|
| 10 |
Letter to the Editor regarding the article “Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis”
|
Yang, Tingfang
|
|
|
162 |
C |
p.
|
article
|
| 11 |
Managing side effects of immune checkpoint inhibitors in breast cancer
|
Criscitiello, Carmen
|
|
|
162 |
C |
p.
|
article
|
| 12 |
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer
|
Berti, Alvise
|
|
|
162 |
C |
p.
|
article
|
| 13 |
Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review
|
Hirte, Hal
|
|
|
162 |
C |
p.
|
article
|
| 14 |
Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy
|
Aran, Veronica
|
|
|
162 |
C |
p.
|
article
|
| 15 |
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance
|
Vitale, Silvia Rita
|
|
|
162 |
C |
p.
|
article
|
| 16 |
Risk Factors of Fluoropyrimidine Induced Cardiotoxicity among Cancer Patients: A Systematic Review and Meta-analysis
|
Li, Chao
|
|
|
162 |
C |
p.
|
article
|
| 17 |
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
|
De Felice, Francesca
|
|
|
162 |
C |
p.
|
article
|
| 18 |
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions
|
Caruso, Giuseppe
|
|
|
162 |
C |
p.
|
article
|
| 19 |
Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?
|
Mir, Tajamul H.
|
|
|
162 |
C |
p.
|
article
|
| 20 |
Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients
|
Devarajan, Nalini
|
|
|
162 |
C |
p.
|
article
|
Journal description